Analytical Tool: Avastin & The Competitive Landscape

Bioseeker's Intelligence Unit releases the ultimate tool to analyze the future competitive situation for Avastin. Reasons to own this Analytical Tool. This is the only product that provides you with a complete structure of the areas involved in analyzing Avastin. It covers areas such as: colorectal, breast and lung cancer, monoclonal antibodies, antiangiogenesis, protein kinase inhibitors, and VEGF/VEGFr inhibition. You will be able to study areas in conjunction to Avastin, structured by cancer type, drug effect and drug mechanisms/targets. To track cutting edge competitive companies, therapies and technologies in the future market. You will save time by rapid identification and analysis of competitors. Evaluate progress in both standard cytotoxic as well as novel treatments competing with Avastin.

(PRWEB) October 11, 2004 -- "Avastin & The Competitive Landscape" offers a unique tool for analyzing the complex competitive pressure in which Avastin is positioned. It is at the same time a map of the research and development, an up to date history of the achievements and a guide pointing out the directions of the future. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. Additionally, BioSeeker Group has developed a CD-ROM searchable database, which is highly updated to reflect the most recent advances in the field, in order to help you perform your own specific analysis, go back to the source data for in-depth information, and to offer you an opportunity to present the R&D in tables and graphs suited for your own specific purposes.

A significant advantage with BioSeeker Group's CD-ROM searchable databases is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker Group CD-ROM searchable databases provide you with a better overview and specific search capabilities.

For your convenience, information about new innovative cancer therapies such as antisense, monoclonal antibodies, gene therapy, antigen- or cellular-based vaccines, liposomal hormones, apoptotic drugs and other small molecular drugs are analyzed in hundreds of extensive tables and graphs. "Avastin & The Competitive Landscape" offer you easy-to-read tables with projects classified into well-defined structures based on type of therapy given, effect and mechanism. The graphs provide all the relations of these factors as well as the general and specific trends in this competitive landscape.

For more information about this report, please visit BioSeeker's website.

###